Cargando…
Sheng-Xue-Xiao-Ban Capsule-induced ischemic colitis and pulmonary embolism in an idiopathic thrombocytopenic purpura patient: a rare case report
BACKGROUND: Sheng-Xue-Xiao-Ban Capsule (SXXBC), as a classic Chinese traditional medicine comprised of natural indigo, cortex moutan, forsythia, herba agrimoniae, and licorice, exhibits a heat-clearing and detoxicating function, hemostasis, and stasis dissipation, which is widely applied to treat id...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577723/ https://www.ncbi.nlm.nih.gov/pubmed/36267749 http://dx.doi.org/10.21037/atm-22-3951 |
_version_ | 1784811821551583232 |
---|---|
author | Zhou, Sisi Shi, Quan Zheng, Yanfeng Zhuang, Yihan Lin, Yiting Huang, Zeyu Yu, Jing |
author_facet | Zhou, Sisi Shi, Quan Zheng, Yanfeng Zhuang, Yihan Lin, Yiting Huang, Zeyu Yu, Jing |
author_sort | Zhou, Sisi |
collection | PubMed |
description | BACKGROUND: Sheng-Xue-Xiao-Ban Capsule (SXXBC), as a classic Chinese traditional medicine comprised of natural indigo, cortex moutan, forsythia, herba agrimoniae, and licorice, exhibits a heat-clearing and detoxicating function, hemostasis, and stasis dissipation, which is widely applied to treat idiopathic thrombocytopenic purpura (ITP). However, report on ischemic colitis and pulmonary embolism induced by SXXBC therapy is never disclosed. We report the case of an ITP patient who received SXXBC for ascending platelets that then induced ischemic colitis and pulmonary embolism. CASE DESCRIPTION: A 74-year-old female patient was admitted in June 2021 due to “bleeding in stool for 1 day,” she was then re-admitted in July 2021 due to “repeated bleeding in stool for 2 days”. Abdominal computed tomography (CT), colonoscopy, and a pathological examination suggested ischemic colitis according to the American College of Gastroenterology (ACG) clinical guidelines. Pulmonary artery CT angiography suggested pulmonary embolism reflected by multiple filling defects, and the patient presented with shortness of breath. It was noted that the patient had started taken SXXBC for ascending platelets 2 months before the onset of hematochezia. After the diagnosis of hematochezia was made, the patient received phenethylamine and carbazochrome for hemostasis, mesalazine enteric-coated tablets for anti-inflammation, and SXXBC was stopped. The hematochezia then ceased, and the ischemic colitis was attenuated. Afterwards, low-molecular-weight heparin was administered, followed by a 3-week treatment of rivaroxaban anticoagulant, which was taken orally after discharge. The pulmonary embolism was then obviously ameliorated. After excluding other causes, the patient was diagnosed with SXXBC–induced ischemic colitis complicated by pulmonary embolism. After conducting research, we came to the view that natural indigo, which is the main component of SXXBC, contributed to the patient’s illness. CONCLUSIONS: Ischemic colitis complicated with pulmonary embolism are rare; however, close attention such as regular abdominal CT test needs to be paid and preventive steps such as anti-coagulant treatment could to be taken (if symptoms occur) when treating patients with SXXBC. |
format | Online Article Text |
id | pubmed-9577723 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-95777232022-10-19 Sheng-Xue-Xiao-Ban Capsule-induced ischemic colitis and pulmonary embolism in an idiopathic thrombocytopenic purpura patient: a rare case report Zhou, Sisi Shi, Quan Zheng, Yanfeng Zhuang, Yihan Lin, Yiting Huang, Zeyu Yu, Jing Ann Transl Med Case Report BACKGROUND: Sheng-Xue-Xiao-Ban Capsule (SXXBC), as a classic Chinese traditional medicine comprised of natural indigo, cortex moutan, forsythia, herba agrimoniae, and licorice, exhibits a heat-clearing and detoxicating function, hemostasis, and stasis dissipation, which is widely applied to treat idiopathic thrombocytopenic purpura (ITP). However, report on ischemic colitis and pulmonary embolism induced by SXXBC therapy is never disclosed. We report the case of an ITP patient who received SXXBC for ascending platelets that then induced ischemic colitis and pulmonary embolism. CASE DESCRIPTION: A 74-year-old female patient was admitted in June 2021 due to “bleeding in stool for 1 day,” she was then re-admitted in July 2021 due to “repeated bleeding in stool for 2 days”. Abdominal computed tomography (CT), colonoscopy, and a pathological examination suggested ischemic colitis according to the American College of Gastroenterology (ACG) clinical guidelines. Pulmonary artery CT angiography suggested pulmonary embolism reflected by multiple filling defects, and the patient presented with shortness of breath. It was noted that the patient had started taken SXXBC for ascending platelets 2 months before the onset of hematochezia. After the diagnosis of hematochezia was made, the patient received phenethylamine and carbazochrome for hemostasis, mesalazine enteric-coated tablets for anti-inflammation, and SXXBC was stopped. The hematochezia then ceased, and the ischemic colitis was attenuated. Afterwards, low-molecular-weight heparin was administered, followed by a 3-week treatment of rivaroxaban anticoagulant, which was taken orally after discharge. The pulmonary embolism was then obviously ameliorated. After excluding other causes, the patient was diagnosed with SXXBC–induced ischemic colitis complicated by pulmonary embolism. After conducting research, we came to the view that natural indigo, which is the main component of SXXBC, contributed to the patient’s illness. CONCLUSIONS: Ischemic colitis complicated with pulmonary embolism are rare; however, close attention such as regular abdominal CT test needs to be paid and preventive steps such as anti-coagulant treatment could to be taken (if symptoms occur) when treating patients with SXXBC. AME Publishing Company 2022-09 /pmc/articles/PMC9577723/ /pubmed/36267749 http://dx.doi.org/10.21037/atm-22-3951 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Case Report Zhou, Sisi Shi, Quan Zheng, Yanfeng Zhuang, Yihan Lin, Yiting Huang, Zeyu Yu, Jing Sheng-Xue-Xiao-Ban Capsule-induced ischemic colitis and pulmonary embolism in an idiopathic thrombocytopenic purpura patient: a rare case report |
title | Sheng-Xue-Xiao-Ban Capsule-induced ischemic colitis and pulmonary embolism in an idiopathic thrombocytopenic purpura patient: a rare case report |
title_full | Sheng-Xue-Xiao-Ban Capsule-induced ischemic colitis and pulmonary embolism in an idiopathic thrombocytopenic purpura patient: a rare case report |
title_fullStr | Sheng-Xue-Xiao-Ban Capsule-induced ischemic colitis and pulmonary embolism in an idiopathic thrombocytopenic purpura patient: a rare case report |
title_full_unstemmed | Sheng-Xue-Xiao-Ban Capsule-induced ischemic colitis and pulmonary embolism in an idiopathic thrombocytopenic purpura patient: a rare case report |
title_short | Sheng-Xue-Xiao-Ban Capsule-induced ischemic colitis and pulmonary embolism in an idiopathic thrombocytopenic purpura patient: a rare case report |
title_sort | sheng-xue-xiao-ban capsule-induced ischemic colitis and pulmonary embolism in an idiopathic thrombocytopenic purpura patient: a rare case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577723/ https://www.ncbi.nlm.nih.gov/pubmed/36267749 http://dx.doi.org/10.21037/atm-22-3951 |
work_keys_str_mv | AT zhousisi shengxuexiaobancapsuleinducedischemiccolitisandpulmonaryembolisminanidiopathicthrombocytopenicpurpurapatientararecasereport AT shiquan shengxuexiaobancapsuleinducedischemiccolitisandpulmonaryembolisminanidiopathicthrombocytopenicpurpurapatientararecasereport AT zhengyanfeng shengxuexiaobancapsuleinducedischemiccolitisandpulmonaryembolisminanidiopathicthrombocytopenicpurpurapatientararecasereport AT zhuangyihan shengxuexiaobancapsuleinducedischemiccolitisandpulmonaryembolisminanidiopathicthrombocytopenicpurpurapatientararecasereport AT linyiting shengxuexiaobancapsuleinducedischemiccolitisandpulmonaryembolisminanidiopathicthrombocytopenicpurpurapatientararecasereport AT huangzeyu shengxuexiaobancapsuleinducedischemiccolitisandpulmonaryembolisminanidiopathicthrombocytopenicpurpurapatientararecasereport AT yujing shengxuexiaobancapsuleinducedischemiccolitisandpulmonaryembolisminanidiopathicthrombocytopenicpurpurapatientararecasereport |